Related references
Note: Only part of the references are listed.Downregulation of BASP1 Promotes Temozolomide Resistance in Gliomas via Epigenetic Activation of the FBXO32/NF-KB/MGMT Axis
Xinyi Liao et al.
MOLECULAR CANCER RESEARCH (2023)
REMARK guidelines for tumour biomarker study reporting: a remarkable history
Daniel F. Hayes et al.
BRITISH JOURNAL OF CANCER (2023)
Small Cell Lung Carcinoma: Current Diagnosis, Biomarkers, and Treatment Options with Future Perspectives
Kristina Krpina et al.
BIOMEDICINES (2023)
The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015
Andrew G. Nicholson et al.
JOURNAL OF THORACIC ONCOLOGY (2022)
Utility of secretagogin as a marker for the diagnosis of lung neuroendocrine carcinoma
Yigit Baykara et al.
VIRCHOWS ARCHIV (2022)
Proteomic Analysis of Lung Cancer Types-A Pilot Study
Simon Sugar et al.
CANCERS (2022)
Identification of Transferrin Receptor 1 (TfR1) Overexpressed in Lung Cancer Cells, and Internalization of Magnetic Au-CoFe2O4 Core-Shell Nanoparticles Functionalized with Its Ligand in a Cellular Model of Small Cell Lung Cancer (SCLC)
Rocio Villalobos-Manzo et al.
PHARMACEUTICS (2022)
In-depth proteomic analysis reveals unique subtype-specific signatures in human small-cell lung cancer
Beata Szeitz et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2022)
Defining Clinical Utility of Tumor Biomarker Tests: A Clinician's Viewpoint
Daniel F. Hayes
JOURNAL OF CLINICAL ONCOLOGY (2021)
Small-cell lung cancer
Charles M. Rudin et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Quantitative proteomic analysis of glycosylated proteins enriched from urine samples with magnetic ConA nanoparticles identifies potential biomarkers for small cell lung cancer
Zhiyu Zhang et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2021)
ENO3 Inhibits Growth and Metastasis of Hepatocellular Carcinoma via Wnt/β-Catenin Signaling Pathway
Honglei Cui et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Plasma Based Protein Signatures Associated with Small Cell Lung Cancer
Johannes F. Fahrmann et al.
CANCERS (2021)
Prognostic value of baseline hemoglobin-to-red blood cell distribution width ratio in small cell lung cancer: A retrospective analysis
Fangfang Wu et al.
THORACIC CANCER (2020)
Proteomic Analysis of the Air-Way Fluid in Lung Cancer. Detection of Periostin in Bronchoalveolar Lavage (BAL)
Yangying Zhou et al.
FRONTIERS IN ONCOLOGY (2020)
BASP1 Suppresses Cell Growth and Metastasis through Inhibiting Wnt/β-Catenin Pathway in Gastric Cancer
Li Li et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression
Ching-Chan Lin et al.
THERANOSTICS (2020)
Improving the translation of search strategies using the Polyglot Search Translator: a randomized controlled trial
Justin Michael Clark et al.
JOURNAL OF THE MEDICAL LIBRARY ASSOCIATION (2020)
Differential Expression of TOM34, AL1A1, PADI2 and KLRBA in NNK Induced Lung Cancer in Wistar Rats and their Implications
Mohammad Asad et al.
CURRENT CANCER DRUG TARGETS (2019)
Identification of key modules and hub genes for small-cell lung carcinoma and large-cell neuroendocrine lung carcinoma by weighted gene co-expression network analysis of clinical tissue-proteomes
Haruhiko Nakamura et al.
PLOS ONE (2019)
Coactosin-like protein CLP/Cot11 suppresses breast cancer growth through activation of IL-24/PERP and inhibition of non-canonical TGF beta signaling
L. Xia et al.
ONCOGENE (2018)
New Insights into the Molecular Characteristics of Pulmonary Carcinoids and Large Cell Neuroendocrine Carcinomas, and the Impact on Their Clinical Management
Jules L. Derks et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors
Julie George et al.
NATURE COMMUNICATIONS (2018)
A selected reaction monitoring mass spectrometric assessment of biomarker candidates diagnosing large-cell neuroendocrine lung carcinoma by the scaling method using endogenous references
Tetsuya Fukuda et al.
PLOS ONE (2017)
Neuron-specific enolase and response to initial therapy are important prognostic factors in patients with small cell lung cancer
M. Zhou et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2017)
Rayyan-a web and mobile app for systematic reviews
Mourad Ouzzani et al.
SYSTEMATIC REVIEWS (2016)
The 2015 World Health Organization Classification of Lung Tumors Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Integrated Glycoproteomics Demonstrates Fucosylated Serum Paraoxonase 1 Alterations in Small Cell Lung Cancer
Jung-Mo Ahn et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/β-catenin signaling pathway in human lung cancer
Linlin Yang et al.
CARCINOGENESIS (2012)
Personalized Medicine for Non-Small-Cell Lung Cancer: Implications of Recent Advances in Tissue Acquisition for Molecular and Histologic Testing
Andre L. Moreira et al.
CLINICAL LUNG CANCER (2012)
Small-Cell Lung Cancer: Prognostic Factors and Changing Treatment Over 15 Years
Laurie E. Gaspar et al.
CLINICAL LUNG CANCER (2012)
Support vector machines coupled with proteomics approaches for detecting biomarkers predicting chemotherapy resistance in small cell lung cancer
Mingyong Han et al.
ONCOLOGY REPORTS (2012)
Matrix-assisted laser desorption/ionization mass spectrometry reveals decreased calcylcin expression in small cell lung cancer
Hee Seok Lee et al.
PATHOLOGY INTERNATIONAL (2012)
Identification of serum biomarkers for lung cancer using magnetic bead-based SELDI-TOF-MS
Qi-bin Song et al.
ACTA PHARMACOLOGICA SINICA (2011)
Proteomic Analysis of Human Small Cell Lung Cancer Tissues: Up-Regulation of Coactosin-Like Protein-1
Hye-Cheol Jeong et al.
JOURNAL OF PROTEOME RESEARCH (2011)
The Haptoglobin beta chain as a supportive biomarker for human lung cancers
Sung-Min Kang et al.
MOLECULAR BIOSYSTEMS (2011)
Differential Serum Level of Specific Haptoglobin Isoforms in Small Cell Lung Cancer
Ankur Shah et al.
CURRENT PROTEOMICS (2010)
Randomized Clinical Trials With Biomarkers: Design Issues
Boris Freidlin et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
QUADOMICS: An adaptation of the Quality Assessment of Diagnostic Accuracy Assessment (QUADAS) for the evaluation of the methodological quality of studies on the diagnostic accuracy of '-omics'-based technologies
Blanca Lumbreras et al.
CLINICAL BIOCHEMISTRY (2008)
Lipoxygenase metabolism: roles in tumor progression and survival
Graham P. Pidgeon et al.
CANCER AND METASTASIS REVIEWS (2007)
Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical, and molecular analysis
Kenzo Hiroshima et al.
MODERN PATHOLOGY (2006)
Coactosin-like protein supports 5-lipoxygenase enzyme activity and up-regulates leukotriene A4 production
Marija Rakonjac et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung
JH Park et al.
RESPIROLOGY (2006)
Immunohistochemical distinction between Merkel cell carcinoma and small cell carcinoma of the lung
Mattheos Bobos et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2006)
CD56: a useful tool for the diagnosis of small cell lung carcinomas on biopsies with extensive crush artefact
K Kontogianni et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Clinical trial designs for predictive marker validation in cancer treatment trials
DJ Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Fucosylation of serum glycoproteins in lung cancer patients
B Kossowska et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2005)
Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer
N Ahmed et al.
BRITISH JOURNAL OF CANCER (2004)
Share Paper
